COVID-19 vaccines: Global challenges and prospects forum recommendations.

Boudjelal M., Almajed F., Salman AM., Alharbi NK., Colangelo M., Michelotti JM., Olinger G., Baker M., Hill AVS., Alaskar A.

The 11th KAIMRC Annual Research Forum Themed "COVID-19 Vaccine: Global Challenges and Prospects Forum" discussed COVID19 Vaccines. The Forum was a vital event as it provided a hub for leading COVID-19 vaccine scientists, regulators, developers, and distributors to learn about COVID-19 vaccines in development, make decisions about the best vaccines to use, and develop appropriate plans for global distribution and pricing. The COVID-19: Global Efforts for Development, Clinical Trials and Distribution Symposium brought together leading scientists, clinicians, pharma, decision makers, academic institutions and businesses to present and discuss the vaccines that are being currently developed for the COVID19. This event was held to shed light on these vaccines as many are at the late stage of Phase III clinical trials and ready to be marketed. This follows the confusion that few vaccines were produced and pushed into phase III without sharing all the necessary data preventing the scientific and clinical community to judge its efficacy and safety. This event allowed a discussion into the challenges in the distribution, pricing and accessibility of the vaccines. Moreover, the symposium discussed the importance to invest in Biotech-Pharma to combat and overcome any future health crisis. The discussion focused on Saudi Arabia leading initiatives as front runner in the field among G20 members.

DOI

10.1016/j.ijid.2021.02.093

Type

Journal article

Publication Date

2021-04-01T00:00:00+00:00

Volume

105

Pages

448 - 451

Total pages

3

Addresses

King Abdullah International Medical Research Centre, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia. Electronic address: boudjelalmo@ngha.med.sa.

Keywords

Humans, Costs and Cost Analysis, Delivery of Health Care, Health Services Accessibility, Saudi Arabia, Practice Guidelines as Topic, Drug Development, COVID-19, SARS-CoV-2, COVID-19 Vaccines

Permalink More information Close